Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. - Wikidata - wikimedia - TriplyDB

Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden.

Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden.

http://www.wikidata.org/entity/Q48217013

about

(-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model Spines, plasticity, and cognition in Alzheimer's model mice Impact of pyrrolidine dithiocarbamate and interleukin-6 on mammalian target of rapamycin complex 1 regulation and global protein translation Towards understanding brain-gut-microbiome connections in Alzheimer's disease Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.Lipopolysaccharides up-regulate Kir6.1/SUR2B channel expression and enhance vascular KATP channel activity via NF-kappaB-dependent signaling c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo.RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology Pharmacological and genetic reversal of age-dependent cognitive deficits attributable to decreased presenilin function Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease Synaptic changes in the dentate gyrus of APP/PS1 transgenic mice revealed by electron microscopy.Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.GSK-3 in Neurodegenerative Diseases.Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer's disease.Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation.Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.Copper modulation as a therapy for Alzheimer's disease?Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes.Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.Abnormal Population Responses in the Somatosensory Cortex of Alzheimer's Disease Model Mice.The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation.Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.Neuroendocrine immunomodulation network dysfunction in SAMP8 mice and PrP-hAβPPswe/PS1ΔE9 mice: potential mechanism underlying cognitive impairment.Pharmacotherapeutic targets in Alzheimer's disease Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.Susceptibility to focal and global brain ischemia of Alzheimer mice displaying aβ deposits: effect of immunoglobulin Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway.Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease?Metal attenuating therapies in neurodegenerative disease.

P2860

Q27334259-B2AD7044-C1A5-4F10-9ED5-3730F0158B4B Q27691328-24AC037E-527C-4F0A-ADBA-22CDF1186F04 Q28394212-37D8D452-C45E-4316-97E5-3A4AA569028A Q28831443-549737A6-02E1-44D6-BC45-6380A5C77F9C Q30423207-0DF1ED7B-3111-49C2-AEA7-A6879DCB9109 Q33661652-11267938-497A-49D9-AAE0-700C7817D4BD Q33695108-3603AA11-A2CE-4A65-B26A-E127110F1F4A Q33963659-1468C830-F9B1-4784-A83A-E3C27E3AFE62 Q33995580-9BE66D5A-FF3A-46CC-9C8F-C65CBA50EE29 Q34050670-927F2DE7-4311-4E6C-B086-F8A957D3F5A3 Q34419295-155B9A85-27D9-422F-A377-7D42DDEEAA2E Q34667356-FEC5BF6F-B261-478E-AE70-213487D210B2 Q34989710-AD9F2D17-FA71-4B0D-9D04-0BFF8B517D81 Q35001040-B774A7F8-2802-42AD-AC1A-744417F8A666 Q35052443-CEF81FA3-1758-4AC0-9886-1406A9373D4B Q35108628-A18EFBFD-8351-424D-9535-EE7D3D6A5BA6 Q35137333-559C20FD-3CDC-4319-B793-8C9A44215B7A Q35184353-09D2F9BF-0BB9-4A12-93FB-6FB7D4D6A462 Q35635988-79E3F316-2DDA-45FA-8C10-1E120DBAB6B9 Q36088590-92091951-00FA-435E-95A7-097553CABE79 Q36515716-D86A852B-3DFC-4C6C-99DA-CE53320B302E Q36622182-D9FC48FE-CA2D-47A7-9748-0B82E6878670 Q36761675-FFD9F93D-1B70-4C71-994C-7744D7904525 Q36799532-FB4BC731-DD97-49FA-8380-66364E95FFB6 Q36872887-C0F6018C-EE9A-4CF2-A123-9494FA2DA55C Q36930615-420A1987-2689-4E57-8F3F-FB20747AA2FB Q37061979-8521C1B0-2267-497F-A05F-F0ECCED094EF Q37132181-2D52A659-4E49-43F1-8762-D10D4CEC5B10 Q37174350-2DE42F2C-1351-449F-8E10-D2C773893E9E Q37268924-41E484A5-4B21-47AD-8755-5FDE8E372B0F Q37295067-28A4DE66-01F0-4602-88A7-E90D9DD5543A Q37364086-B51B771E-8C7F-4E6A-9D9A-06D29CE1233B Q37373364-3199A28F-27D1-406A-88DA-3E2753F394B6 Q37439850-FFD79769-3446-4F8E-BA10-3648C2E8A5F7 Q37665371-B0FDE018-D1B0-48AE-9A1A-232D5B4A2FD4 Q37693458-36FCA4FF-3D22-472B-8E8C-314150628493 Q37725605-65977098-51F6-4431-8D25-B0A4E9A28D3C Q37883102-9C057BC1-A0C7-408E-AF61-51D868439066 Q37883104-36B17BAA-0E68-4635-BFDF-FC1B06EBDB58 Q37957126-904A6915-99F5-4A4C-A05A-897B92E82CFF

P2860

Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden.

http://www.wikidata.org/entity/Q48217013

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@en

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@nl

type

label

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@en

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@nl

prefLabel

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@en

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@nl

P1433

Q48217013-40236DF7-9EC3-4B24-8025-6E7768A5AC1F

P1476

Q48217013-CBA1A4F9-BA03-4F3C-B784-EF6FBE9219AB

P2093

Q48217013-070FEC55-9384-4FF1-864C-772479B73DF2

Q48217013-465CD31C-15C0-489D-AFD6-90A114A44C70

Q48217013-5689DF36-4B22-4DA6-BE57-003DF3783438

Q48217013-722FF5FC-E560-47B8-95C5-6A7D37C7B391

Q48217013-723ED635-F35B-4663-9F9F-6F0415B020A1

Q48217013-96C96A17-0796-4475-82E2-ADCA801258D7

Q48217013-AFF5FB45-F3F6-4904-9771-438E461BEEEC

Q48217013-BD4A5D8F-95E6-4C4C-B8C6-37F40EB673F2

Q48217013-EC648439-E730-46B8-921B-7099CD2FF18B

Q48217013-FE9A282C-5BFC-4367-BE64-99EF07B66B0F

P304

Q48217013-84A7D9D0-A478-4AB7-BA31-EE8570C733F6

P31

Q48217013-1A258B93-887A-448D-8E33-945346E1B78C

P356

Q48217013-27C26BAF-7B17-4F58-BC6C-F9BD298B34F5

P407

Q48217013-EA76BE1C-0190-4005-9129-84BF6698190D

P433

Q48217013-BCCEDFF4-4B64-4FBD-BB7A-966B3AA14BCA

P478

Q48217013-3F7A3948-9879-4D3E-98A5-19266E5358A5

P50

Q48217013-4F7A48DC-55E6-452E-9F5C-601F07F126E1

P577

Q48217013-9C11E656-E25C-4E79-9234-009D5EDC5696

P5875

Q48217013-D33D8665-49C2-43CD-B1DA-58534EDF3A6D

P698

Q48217013-453146D0-ECCE-4B0D-866F-2EF491B3180D

P932

Q48217013-9F74FF6D-A5BA-4C28-9E89-F173D2299C0E

P356

JNEUROSCI.0059-07.2007

P1433

Journal of Neuroscience

P1476

Pyrrolidine dithiocarbamate ac ...... affecting beta-amyloid burden.

@en

P2093

Antero Salminen

http://www.w3.org/2001/XMLSchema#string

Gundars Goldsteins

http://www.w3.org/2001/XMLSchema#string

Heikki Tanila

http://www.w3.org/2001/XMLSchema#string

Henna Iivonen

http://www.w3.org/2001/XMLSchema#string

Jari Koistinaho

http://www.w3.org/2001/XMLSchema#string

Katja Kanninen

http://www.w3.org/2001/XMLSchema#string

Seppo Auriola

http://www.w3.org/2001/XMLSchema#string

Thomas Van Groen

http://www.w3.org/2001/XMLSchema#string

Toni Ahtoniemi

http://www.w3.org/2001/XMLSchema#string

Velta Keksa-Goldsteine

http://www.w3.org/2001/XMLSchema#string

P304

3712-3721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.0059-07.2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6413193

http://www.w3.org/2001/XMLSchema#string

P698

17409235

http://www.w3.org/2001/XMLSchema#string

P932

6672417

http://www.w3.org/2001/XMLSchema#string